XML 30 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Debt
3 Months Ended
Mar. 31, 2022
Debt Disclosure [Abstract]  
Debt Debt
March 31, 2022December 31, 2021
5.125% Notes, due 2024
$1,150 $1,150 
6.875% Notes, due 2025
600 600 
5.900% Notes, due 2027
625 625 
6.750% Bonds, due 2028
300 300 
3.000% Notes, due 2029
700 700 
5.950% Notes, due 2037
625 625 
4.750% Iowa Finance Authority Loan, due 2042
250 250 
Other(1)
(19)(18)
4,231 4,232 
Less: amount due within one year
Total long-term debt$4,228 $4,227 
 
(1)Includes various financing arrangements related to subsidiaries, unamortized debt discounts and unamortized debt issuance costs related to outstanding notes and bonds listed in the table above.
Public Debt
On January 15, 2021, the Company completed the early redemption of all the remaining $361 of its 5.400% Notes due 2021 at par and paid $5 in accrued interest.
Credit Facility
On September 28, 2021, the Company amended and restated its Credit Agreement. The Credit Agreement provides a $1,000 senior unsecured revolving credit facility that matures on September 28, 2026, unless extended or earlier terminated in accordance with the provisions of the Credit Agreement. Capitalized terms used in this “Credit Facility” section but not otherwise defined shall have the meanings given to such terms in the Credit Agreement.
Under the Credit Agreement, the Company’s ratio of Consolidated Net Debt to Consolidated EBITDA as of the end of each fiscal quarter for the period of the four fiscal quarters of the Company most recently ended, is required to be no greater than 3.50 to 1.00; provided, however, that during the Covenant Relief Period through December 31, 2022 (unless the Company elects to terminate the Covenant Relief Period earlier in accordance with the Credit Agreement), the Company’s Consolidated Net Debt to Consolidated EBITDA ratio cannot exceed the levels set forth below:
No greater than
  (i) for the quarter ending March 31, 2022
4.50 to 1.00
 (ii) for the quarter ending June 30, 2022
4.50 to 1.00
(iii) for the quarter ending September 30, 2022
4.25 to 1.00
(iv) for the quarter ending December 31, 2022
3.75 to 1.00
During the Covenant Relief Period, common stock dividends and share repurchases (see Note H) are permitted only if no loans under the Credit Agreement are outstanding at the time and are limited to an aggregate amount not to exceed $500 during the year ending December 31, 2022. Common stock dividends and share repurchases were $183 for the first quarter of 2022.
There were no amounts outstanding under the Credit Agreement at March 31, 2022 or December 31, 2021, and no amounts were borrowed during 2022 or 2021 under the Credit Agreement. At March 31, 2022, the Company was in compliance with all covenants under the Credit Agreement. Availability under the Credit Agreement could be reduced in future periods if the Company fails to maintain the required ratios referenced above.